New Legislation Emerges to Enhance Drug Safety and Boost Vaccine Availability

Agadir24

The Government Council approved, today, Thursday, September 12, 2024, the draft decree-law No. 2.24.728 amending Law No. 17.04 as the Code of Medicines and Pharmacy, presented by the Minister of Health and Social Protection, Khalid Ait Taleb.

The Minister Delegate in charge of Relations with Parliament, Government Spokesman, Mustapha Baitas, explained during a press conference following the weekly meeting of the Council, that this project comes in the context of the challenges posed by the Covid-19 pandemic related to the drug security of our country, as this global health crisis has revealed the urgent need to ensure the sustainability and availability of medicines, especially vaccines, as a vital material to confront health crises and enhance health care.

Mr. Baitas pointed out that this project aims to achieve vaccine sovereignty for our country by establishing a national industry that responds to national and continental demand, keeping pace with this industry and ensuring the quality of locally manufactured or imported vaccines, and verifying that they meet internationally recognized standards.

Given the urgency of the process of establishing an effective and integrated legal framework, Mr. Baitas added, a draft decree-law has been prepared that aims, in particular, to create a national system for the official recognition of the suitability of vaccine and serum lots intended for human use for packaging and marketing.

According to the Minister, this system aims to establish a procedure for reviewing production data and quality control test results for each batch of vaccine or serum intended for human use that has been subject to a market placement authorization.

#government #approves #draft #law #enhance #drug #security #provide #vaccines. #Details
2024-09-14 17:53:20

What ⁣are ⁣the main objectives ‍of Morocco‘s decree-law No. 2.24.728 regarding vaccine​ sovereignty?

Agadir24: ​Morocco Takes ‌a Leap towards Vaccine Sovereignty with Latest Decree-Law

On September 12, 2024,‍ the Moroccan Government Council approved draft decree-law No. 2.24.728, amending Law No. 17.04 as the ‌Code of Medicines and Pharmacy. This⁣ significant move aims⁤ to bolster the country’s ⁢vaccine security and ⁤self-sufficiency, particularly in the wake of the​ Covid-19 pandemic. In ‌this article, we will delve into the details ⁢of this development and its implications for Morocco’s healthcare system.

Context and Background

The Covid-19 pandemic has highlighted‍ the importance of ensuring the‌ sustainability and availability of medicines, especially vaccines, to ‌combat ⁣health crises. The ⁣global health ⁣emergency has exposed the vulnerability of countries reliant⁢ on‌ imported vaccines and medicines. Morocco, being no exception, has ⁢recognized the ‍urgent need to establish a self-sufficient national industry capable of meeting the country’s healthcare demands.

Objectives​ of the Decree-Law

The‍ approved decree-law ‌aims‌ to achieve vaccine sovereignty for Morocco ⁣by:

  1. Establishing a national industry: The law seeks to create a domestic industry that⁤ caters to national and continental demand, keeping pace with‌ international standards and best practices.
  2. Ensuring quality and standards: The industry will focus on⁢ producing high-quality vaccines that meet internationally recognized standards, ensuring the ‍health and ⁤well-being of Moroccan citizens.
  3. Verifying vaccine quality: The law will enable the verification of⁣ locally manufactured or imported vaccines, ‌guaranteeing their⁤ compliance with international standards.

Benefits of⁤ Vaccine ​Sovereignty

Achieving‌ vaccine sovereignty ⁤will⁣ have far-reaching benefits for ​Morocco,‍ including:

  1. Reduced dependence ​on imports: By producing vaccines domestically, Morocco will reduce its⁤ reliance on imported ‌vaccines,‌ ensuring ⁣a ‌consistent supply of essential healthcare products.
  2. Improved health outcomes: Having control over vaccine⁢ production ⁢will enable Morocco to ‌respond swiftly to health crises, protecting ⁣its citizens from the risks of vaccine shortages and supply chain disruptions.
  3. Economic growth: A thriving national⁣ vaccine industry will contribute to Morocco’s economic ‌growth, creating new job opportunities ‌and ‍stimulating local entrepreneurship.

Government’s Commitment⁢ to Healthcare

The Moroccan government ⁢has consistently demonstrated its commitment to strengthening‍ the country’s healthcare system. The approval of this decree-law is ​a ​testament‌ to the government’s resolve to‌ ensure⁣ the health and well-being⁣ of its ⁣citizens.

Conclusion

The approval of draft decree-law No. 2.24.728 ‍marks a significant ‍step towards achieving‌ vaccine sovereignty for Morocco. By establishing a⁤ national industry capable of‌ producing ‌high-quality vaccines, ‍Morocco will reduce​ its dependence on⁣ imports, ⁢improve ‌health outcomes, and stimulate economic growth. This development is a⁣ clear indication of the government’s dedication to prioritizing the health ⁢and well-being of⁤ its citizens.

Keyword⁤ Tags:

Agadir24

Morocco

Vaccine Sovereignty

Decree-Law

Covid-19‍ Pandemic

Healthcare System

Vaccine Security

‌ National Industry

‍International Standards

Economic ⁣Growth

Meta Description:

Discover how Morocco is taking a leap towards vaccine sovereignty with the⁢ approval of decree-law No. 2.24.728.‍ Learn about‌ the objectives, ‌benefits, and implications of this ⁤development for Morocco’s healthcare ⁤system.

Word Count: 550 words

Vaccine sovereignty for nations worldwide. How does Morocco’s decree-law No. 2.24.728 support vaccine sovereignty?

Here is the comprehensive and SEO-optimized article on the topic of Agadir24 and Morocco’s decree-law No. 2.24.728 regarding vaccine sovereignty:

Agadir24: Morocco Takes a Leap towards Vaccine Sovereignty with Latest Decree-Law

On September 12, 2024, the Moroccan Government Council approved draft decree-law No. 2.24.728, amending Law No. 17.04 as the Code of Medicines and Pharmacy. This significant move aims to bolster the country’s vaccine security and self-sufficiency, particularly in the wake of the Covid-19 pandemic. In this article, we will delve into the details of this development and its implications for Morocco’s healthcare system.

Context and Background

The Covid-19 pandemic has highlighted the importance of

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.